Our top pick for
Beginners
This article contains links to products or services from one or more of our advertisers or partners. We may receive a commission when you click or make a purchase using our site. Learn more about how we make money.
How to buy Tabula Rasa HealthCare stock | $33.9
Own Tabula Rasa HealthCare stock in just a few minutes.
Tabula Rasa HealthCare, Inc is a health information services business based in the US. Tabula Rasa HealthCare shares (TRHC) are listed on the NASDAQ and all prices are listed in US Dollars. Tabula Rasa HealthCare employs 1,286 staff and has a trailing 12-month revenue of around USD$293.4 million.
How to buy shares in Tabula Rasa HealthCare
- Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
- Search for Tabula Rasa HealthCare. Find the stock by name or ticker symbol: TRHC. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Tabula Rasa HealthCare reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At last close price of USD$33.9, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Tabula Rasa HealthCare, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Tabula Rasa HealthCare. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
Tabula Rasa HealthCare share price
Use our graph to track the performance of TRHC stocks over time.Tabula Rasa HealthCare shares at a glance
Information last updated 2020-12-03.
| Latest market close | USD$33.9 |
|---|---|
| 52-week range | USD$30.12 - USD$69.72 |
| 50-day moving average | USD$36.1997 |
| 200-day moving average | USD$47.6174 |
| Wall St. target price | USD$44.33 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | USD$-0.893 |
Buy Tabula Rasa HealthCare shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Tabula Rasa HealthCare stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Tabula Rasa HealthCare price performance over time
Historical closes compared with the close of $33.9 from 2020-11-16
| 1 week (2020-11-25) | -3.12% |
|---|---|
| 1 month (2020-11-06) | -3.56% |
| 3 months (2020-09-04) | -32.31% |
| 6 months (2020-06-05) | -41.35% |
| 1 year (2019-12-05) | -18.57% |
|---|---|
| 2 years (2018-12-04) | -53.16% |
| 3 years (2017-12-05) | 16.90% |
| 5 years (2015-12-02) | N/A |
Is Tabula Rasa HealthCare under- or over-valued?
Valuing Tabula Rasa HealthCare stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Tabula Rasa HealthCare's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Tabula Rasa HealthCare's PEG ratio
Tabula Rasa HealthCare's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.2633. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Tabula Rasa HealthCare's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Tabula Rasa HealthCare's EBITDA
Tabula Rasa HealthCare's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$691,000.
The EBITDA is a measure of a Tabula Rasa HealthCare's overall financial performance and is widely used to measure a its profitability.
Tabula Rasa HealthCare financials
| Revenue TTM | USD$293.4 million |
|---|---|
| Gross profit TTM | USD$103.4 million |
| Return on assets TTM | -5.82% |
| Return on equity TTM | -32.71% |
| Profit margin | -19.48% |
| Book value | $7.499 |
| Market capitalisation | USD$832.6 million |
TTM: trailing 12 months
Shorting Tabula Rasa HealthCare shares
There are currently 5.5 million Tabula Rasa HealthCare shares held short by investors – that's known as Tabula Rasa HealthCare's "short interest". This figure is 5.3% up from 5.2 million last month.
There are a few different ways that this level of interest in shorting Tabula Rasa HealthCare shares can be evaluated.
Tabula Rasa HealthCare's "short interest ratio" (SIR)
Tabula Rasa HealthCare's "short interest ratio" (SIR) is the quantity of Tabula Rasa HealthCare shares currently shorted divided by the average quantity of Tabula Rasa HealthCare shares traded daily (recently around 297383.04535637). Tabula Rasa HealthCare's SIR currently stands at 18.52. In other words for every 100,000 Tabula Rasa HealthCare shares traded daily on the market, roughly 18520 shares are currently held short.
However Tabula Rasa HealthCare's short interest can also be evaluated against the total number of Tabula Rasa HealthCare shares, or, against the total number of tradable Tabula Rasa HealthCare shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Tabula Rasa HealthCare's short interest could be expressed as 0.23% of the outstanding shares (for every 100,000 Tabula Rasa HealthCare shares in existence, roughly 230 shares are currently held short) or 0.2947% of the tradable shares (for every 100,000 tradable Tabula Rasa HealthCare shares, roughly 295 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Tabula Rasa HealthCare.
Find out more about how you can short Tabula Rasa HealthCare stock.
Tabula Rasa HealthCare share dividends
We're not expecting Tabula Rasa HealthCare to pay a dividend over the next 12 months.
Tabula Rasa HealthCare share price volatility
Over the last 12 months, Tabula Rasa HealthCare's shares have ranged in value from as little as $30.12 up to $69.72. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Tabula Rasa HealthCare's is 1.0005. This would suggest that Tabula Rasa HealthCare's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Tabula Rasa HealthCare overview
Tabula Rasa HealthCare, Inc., together with its subsidiaries, provides patient-specific and data-driven technology and solutions in the field of medication safety in the United States. The company's proprietary Medication Risk Mitigation Matrix delivers a multi-drug review, which identifies medication-related risks. It offers EireneRx, a cloud-based medication decision-support and e-prescribing platform to access patients' medication-related information; and MedWise that provides medication decision support components for clients seeking to manage their medication risk and improve medication outcomes, and patient relationships by enhancing their existing systems. The company's cloud-based software also comprise RxCompanion, an MTM software platform designed to aid in the identification and resolution of medication and other health related problems; TruChart, an electronic health record (EHR) system for Programs of All-Inclusive Care for the Elderly (PACE) organizations; and PACElogic, which delivers real-time sharable workflows comprising EHR, customer relationship management, claims adjudication, electronic data interchange, care management, coordination, planning, integration with community-based providers, and various Federal and State required reporting. In addition, it offers clinical pharmacist collaboration, prescription fulfillment and reminder packaging, and pharmacy cost management services, as well as health plan management services, including risk adjustment and third party administrator services. As of December 31, 2019, the company served 237 healthcare organizations. It provides its cloud-based software solutions to prescribers, pharmacists, pharmacies, and healthcare organizations for managing the medication-related needs of patients. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey.
Frequently asked questions
More guides on Finder
-
How to buy Hertz Global stock | $2.27
Steps to owning and managing HTZ, with 24-hour and historical pricing before you buy.
-
How to buy Helen of Troy stock | $211.57
Steps to owning and managing HELE, with 24-hour and historical pricing before you buy.
-
How to buy Hawaiian Electric Industries stock | $35.92
Steps to owning and managing HE, with 24-hour and historical pricing before you buy.
-
How to buy Glaukos Corporation stock | $70.23
Steps to owning and managing GKOS, with 24-hour and historical pricing before you buy.
-
How to buy Eyenovia stock | $3.87
Steps to owning and managing EYEN, with 24-hour and historical pricing before you buy.
-
How to buy Exact Sciences Corporation stock | $132.87
Steps to owning and managing EXAS, with 24-hour and historical pricing before you buy.
-
How to buy Evofem Biosciences stock | $2.22
Steps to owning and managing EVFM, with 24-hour and historical pricing before you buy.
-
How to buy Everspin Technologies stock | $5.3
Steps to owning and managing MRAM, with 24-hour and historical pricing before you buy.
-
How to buy Equinor ASA stock | $16.73
Steps to owning and managing EQNR, with 24-hour and historical pricing before you buy.
-
How to buy Electrameccanica Vehicles stock | $6.85
Steps to owning and managing SOLO, with 24-hour and historical pricing before you buy.
Ask an Expert